COLL
COLLEGIUM PHARMACEUTICAL, INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.01
−0.78%Forward multiples
Based on analyst estimates
- P/E forward
- 3.31x
- P/E 2026E
- 3.14x
- P/E 2027E
- 3.23x
- P/E 2028E
- 3.05x
- P/S forward
- 0.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.04x
- PEG TTM
- 0.04x
- Price / book
- 2.29x
- Price / sales
- 0.88x
- Price / cash flow
- 2.16x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 1.78x
- EV / EBITDA
- 3.05x
- EV / EBIT
- 9.09x
- Market cap
- $713.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026